• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿替普酶对高血压脑出血患者动脉血栓模型的溶解作用

Dissolution Effect of Alteplase on Arterial Blood Clot Model of Hypertensive Intracerebral Hemorrhage Patients .

作者信息

Jiang Xiaoming, Lu Yongyu, Hu Xiaogang, She Xiaochun

机构信息

Department of Neurosurgery, Rudong Hospital Affiliated to Nantong University, Nantong, China.

Department of Neurosurgery, Haimen District People's Hospital, Nantong, China.

出版信息

Front Neurol. 2022 Feb 18;13:729727. doi: 10.3389/fneur.2022.729727. eCollection 2022.

DOI:10.3389/fneur.2022.729727
PMID:35250799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8894242/
Abstract

OBJECTIVE

To explore the dissolution effect of alteplase (rt-PA) on arterial blood clots of patients with hypertensive cerebral hemorrhage and analyze the optimal concentration and action time of rt-PA for intracranial hematomas.

METHODS

The arterial blood of 35 patients with confirmed hypertensive cerebral hemorrhage were collected, centrifuged, and the serum was aspirated to prepare the blood clot model. The 0.125, 0.25, 0.5, 1, 2, and 3 mg t-PA, 20,000 U, and 40,000 U urokinase (u-PA) were taken for the corresponding blood clot for dissolution test. The blood clot volume and dissolution volume was measured at 0, 30, 60, 90, 120, and 150 min.

RESULTS

Without intervention, the blood clot volume of men was higher than that of women at 0, 30, 60, and 90 min ( < 0.05). Without intervention, hematocrit (HCT) was correlated with blood clot volume and the correlation decreased with time. The 30, 60, and 90 min dissolution curves of each group showed an upward trend ( < 0.05), and the dissolution curves tended to be flat at 120 min and 150 min. The dissolution volume of.125 mg/3 ml, 0.25 mg/3 ml, 0.5 mg/3 ml rt-PA, 20,000 U, 40,000 U u-PA was higher than that of 1, 2, 3 mg/ml rt-PA ( < 0.05). The dissolution volume of.125 mg/3 ml, 0.25 mg/3 ml, 0.5 mg/3 ml rt-PA was not significantly different from 20,000 and 40,000 U u-PA ( > 0.05). Gender differences did not affect the effects of the above drugs.

CONCLUSION

, low-concentration rt-PA has a better dissolution effect, and it shows a time-dependent effect, reaching the highest effect in 90 min.

摘要

目的

探讨阿替普酶(rt-PA)对高血压脑出血患者动脉血栓的溶解作用,分析rt-PA对颅内血肿的最佳浓度及作用时间。

方法

收集35例确诊为高血压脑出血患者的动脉血,离心后吸取血清制备血栓模型。分别取0.125、0.25、0.5、1、2和3mg t-PA、20000U及40000U尿激酶(u-PA)对相应血栓进行溶解试验。于0、30、60、90、120和150分钟测量血栓体积及溶解体积。

结果

未干预时,男性在0、30、60和90分钟时的血栓体积高于女性(P<0.05)。未干预时,血细胞比容(HCT)与血栓体积相关,且相关性随时间降低。各组30、60和90分钟的溶解曲线呈上升趋势(P<0.05),120分钟和150分钟时溶解曲线趋于平缓。0.125mg/3ml、0.25mg/3ml、0.5mg/3ml rt-PA、20000U、40000U u-PA的溶解体积高于1、2、3mg/ml rt-PA(P<0.05)。0.125mg/3ml、0.25mg/3ml、0.5mg/3ml rt-PA的溶解体积与20000和40000U u-PA无显著差异(P>0.05)。性别差异不影响上述药物的作用效果。

结论

低浓度rt-PA具有较好的溶解效果,且呈时间依赖性,90分钟时达到最高效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/8894242/b1efd2e6cd04/fneur-13-729727-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/8894242/b1efd2e6cd04/fneur-13-729727-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/8894242/b1efd2e6cd04/fneur-13-729727-g0001.jpg

相似文献

1
Dissolution Effect of Alteplase on Arterial Blood Clot Model of Hypertensive Intracerebral Hemorrhage Patients .阿替普酶对高血压脑出血患者动脉血栓模型的溶解作用
Front Neurol. 2022 Feb 18;13:729727. doi: 10.3389/fneur.2022.729727. eCollection 2022.
2
Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab. Results from an in vitro study with whole blood clots and platelet-rich clots.超声溶栓术联合重组组织型纤溶酶原激活物有效,但与阿昔单抗无效。这是一项在全血凝块和富含血小板凝块的体外研究中的结果。
Thromb Haemost. 2009 Dec;102(6):1274-7. doi: 10.1160/TH09-03-0207.
3
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(u-PA)和K1K2Pu(一种t-PA/u-PA嵌合体)的溶栓特性比较
J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m.
4
Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).添加不同浓度重组组织型纤溶酶原激活剂(Rt-PA)后新生儿和成人全血凝块的溶解情况。
Semin Thromb Hemost. 1998;24(6):599-604. doi: 10.1055/s-2007-996060.
5
Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.阿替普酶、替奈普酶和尿激酶在脑出血体外血凝块模型中的纤溶特性比较分析。
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105073. doi: 10.1016/j.jstrokecerebrovasdis.2020.105073. Epub 2020 Jun 29.
6
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
7
Effect of Clot Stiffness on Recombinant Tissue Plasminogen Activator Lytic Susceptibility in Vitro.体外血凝块硬度对重组组织型纤溶酶原激活剂溶栓敏感性的影响
Ultrasound Med Biol. 2018 Dec;44(12):2710-2727. doi: 10.1016/j.ultrasmedbio.2018.08.005. Epub 2018 Sep 26.
8
Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA.人组织型纤溶酶原激活剂(t-PA)与血凝块的结合及血凝块结合型t-PA的溶栓活性。
J Pharmacobiodyn. 1990 Dec;13(12):745-50. doi: 10.1248/bpb1978.13.745.
9
Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.含重组组织型纤溶酶原激活剂(rt-PA)的血浆轴向湍流在体外可促进非闭塞性全血凝块的溶栓作用。
Thromb Haemost. 2004 Mar;91(3):487-96. doi: 10.1160/TH03-07-0447.
10
Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro.重组纤溶酶原激活剂BM 06.022在人血浆和体外血凝块系统中的不同纤溶特性
Blood Coagul Fibrinolysis. 1993 Apr;4(2):235-42. doi: 10.1097/00001721-199304000-00004.

引用本文的文献

1
Minimally invasive puncture combined with a high frequency of urokinase therapy improves outcomes in patients with HICH.微创穿刺联合高频尿激酶治疗可改善 HICH 患者的预后。
Neurotherapeutics. 2024 Jan;21(1):e00293. doi: 10.1016/j.neurot.2023.10.003. Epub 2023 Dec 21.

本文引用的文献

1
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.微创血肿清除术与溶栓治疗脑出血的疗效和安全性(MISTIE III):一项随机、对照、开放标签、盲终点 3 期试验。
Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7.
2
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update.脑出血的流行病学、危险因素及临床特征:最新进展
J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.
3
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.
组织型纤溶酶原激活剂(tPA)对神经元存活的影响。
Front Cell Neurosci. 2015 Oct 16;9:415. doi: 10.3389/fncel.2015.00415. eCollection 2015.
4
Minimally invasive treatment of intracerebral hemorrhage.脑出血的微创治疗
Expert Rev Neurother. 2015;15(8):919-33. doi: 10.1586/14737175.2015.1059755.
5
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.自发性脑出血管理指南:美国心脏协会/美国中风协会医疗保健专业人员指南。
Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28.
6
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial.自发性幕上大脑半球脑内血肿患者的早期手术与初始保守治疗(STICH II):一项随机试验。
Lancet. 2013 Aug 3;382(9890):397-408. doi: 10.1016/S0140-6736(13)60986-1. Epub 2013 May 29.
7
Tissue plasminogen activator regulates Purkinje neuron development and survival.组织型纤溶酶原激活物调节浦肯野神经元的发育和存活。
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2410-9. doi: 10.1073/pnas.1305010110. Epub 2013 May 14.
8
Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration.组织型纤溶酶原激活物诱导实验性猪颅内出血后迟发性水肿:纤溶酶原激活物抑制剂-1 给药可减轻。
Transl Stroke Res. 2012 Jul;3(Suppl 1):88-93. doi: 10.1007/s12975-012-0188-3. Epub 2012 May 26.
9
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.揭示一种特殊酶原:tPA 的单链形式是一种 NMDA 受体依赖性信号和神经毒性的选择性激活剂。
Cell Death Differ. 2012 Dec;19(12):1983-91. doi: 10.1038/cdd.2012.86. Epub 2012 Jun 29.
10
In vitro and in vivo high-intensity focused ultrasound thrombolysis.体外和体内高强度聚焦超声溶栓。
Invest Radiol. 2012 Apr;47(4):217-25. doi: 10.1097/RLI.0b013e31823cc75c.